opioid

A landmark clinical trial tested a program that incorporated combined one-to-one and group support sessions. It found that one in five individuals were able to discontinue their use of opioids without experiencing an increase in their pain levels after one year. This new treatment option is seen as an alternative to opioid use and holds the potential to significantly improve the quality of life for patients, according to experts.Scientists from the University of Warwick and The James Cook University Hospital in…

Mallinckrodt, the financially troubled pharmaceutical company, is in discussions with a compensation trust for opioid victims as it seeks to potentially reduce the amount of settlement payments by as much as $1 billion, according to people familiar with the matter.  The generic drugmaker exited bankruptcy in 2022 with a $1.7 billion settlement agreement with state and local governments and private plaintiffs who alleged the company played a role in fueling the opioid crisis. It paid $450 million upon emergence…

New research indicates that only 25% of U.S. adolescent addiction treatment facilities offer buprenorphine, the only approved medication for treating opioid addiction in 16-18 year olds. The study, pointing out a stark gap in evidence-based addiction treatment access among young people, calls for enhanced education, funding, and public awareness.NIH-funded study indicates a substantial need to expand access to evidence-based treatment among young people.Only 1 in 4 residential addiction treatment facilities caring for…

HealthTeva, Allergan, CVS and Walgreens say enough states agreed to final agreements, adding to the billions flowing to communities HealthTeva, Allergan, CVS and Walgreens say enough states agreed to final agreements, adding to the billions flowing to communities FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their…

An appeals court has reinstated a Purdue bankruptcy settlement protecting members of the wealthy Sackler family, who haven’t personally filed for bankruptcy, from opioid litigation. An appeals court has reinstated a Purdue bankruptcy settlement protecting members of the wealthy Sackler family, who haven’t personally filed for bankruptcy, from opioid litigation. FOLLOW US ON GOOGLE NEWS Read original article here Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In…

Around 17 million Americans had chronic pain so bad in 2021 that it drastically interfered with their lives, according to a recent study from the Centers for Disease Control and Prevention. The analysis estimates that nearly 52 million American adults—about one in every five—suffered from chronic pain in 2021.Won’t Virtual Reality Make Me Sick?CDC researchers examined recent data collected from the National Health Interview Survey (NHIS), an in-person survey of households meant to be representative of the country as a…

A lifesaving drug that can reverse an opioid overdose will be available on pharmacy shelves without a prescription this summer, a regulatory relaxation that experts herald as an important step in managing the U.S. opioid epidemic. Currently, naloxone is officially classified as prescription-only but is also available from pharmacists in states with a standing order—a directive designed to increase access to public health interventions such as annual flu shots—or a similar protocol. At participating pharmacies, an…

Telemedicine companies are facing a regulatory shift that many entrepreneurs say would undercut their ability to quickly prescribe medication that helps prevent opioid overdoses. During the Covid-19 pandemic, telehealth companies benefited from a waiver of the requirement that patients be seen in-person before receiving a telemedicine prescription for buprenorphine, a controlled substance used to treat opioid addiction.  The... Telemedicine companies are facing a regulatory shift that many…

A highly effective, fast-acting treatment for opioid overdoses will soon be available in the U.S. over-the-counter. On Wednesday, the Food and Drug Administration approved an OTC version of Narcan, a nasal spray formulation of naloxone developed by the company Emergent BioSolutions. Drug policy experts and harm reduction advocates have long called for OTC naloxone, but it’s expected to take months for the switch to be completed and other key details—particularly pricing—are still unknown at this time.Lions on Oxytocin are…

CBD (yellow stick structure) interferes with binding of an opioid (green and red) by stabilizing an opioid receptor (gray) in its inactive form. Credit: Charles KuntzAs the U.S. pushes for wider access to naloxone, a fast-acting opioid antidote, researchers are exploring <span class="glossaryLink" aria-describedby="tt" data-cmtooltip="<div class=glossaryItemTitle>cannabidiol</div><div class=glossaryItemBody>Cannabidiol, commonly called CBD, is a phytocannabinoid discovered in…